摘要 : Objective: The COVID-19 pandemic led to unprecedented temporary federal and state regulatory flexibilities that rapidly transformed medication for opioid use disorder (MOUD) treatment delivery. This study aimed to understand chang... 展开
作者 | Treitler~ Peter C. Bowden~ Cadence F. Lloyd~ James Enich~ Michael Nyaku~ Amesika N. |
---|---|
作者单位 | |
期刊名称 | 《Journal of substance abuse treatment.》 |
总页数 | 7 |
语种/中图分类号 | en / R9 |
关键词 | Medication for opioid use disorder Medication for addiction treatment COVID-19 Telehealth Methadone Buprenorphine BUPRENORPHINE USE UNITED-STATES SUBSTANCE USE |
馆藏号 | N2007EPST0002457 |